BibTex RIS Kaynak Göster

‘Paraparezi’,Metoklopramide Bağlı Nadir Bir Semptom mu?

Yıl 2011, Cilt: 2 Sayı: 2, 41 - 43, 01.04.2011

Sadiye Yolcu Uysal Nesrin Gökben Çetin Önder Tomruk

Öz

Metoklopramid, üst gastrointestinal sistem motilitesini artırmak için
kullanılan prokinetik ve antiemetik bir ajandır. Akut kas güçsüzlüğü
ise acil serviste sık karşılaşılan nöromüsküler acillerden bir tanesidir
ve etyolojisi çeşitlidir. Bizim bu çalışmamızda normal terapötik dozda
metoklopramid tedavisi alan ve 12–24 saat içinde alt ekstremitede kas
güçsüzlüğü gelişen olgu sunulmuş ve bu ilaca bağlı olası yan etkilerin
gözden geçirilmesi amaçlanmıştır.

Anahtar Kelimeler

Metoklopramid Prokinetik Ajan Nöromüsküler Aciller.

Kaynakça

  • Batts KF, Munter DW. Metoclopramid toxicity in an infant. Pedi- atr Emerg Care 1998;14: 39-41.
  • Bateman DN, Rawlins MD, Simpson JM. Extrapiramidal reac- tions with metoclopramide. BMJ 1985;291:930-932.
  • Guala A, Mittino D, Ghini T, Quazza G. Are metoclopramide dys- tonias familial? Pediatr Med Chir 1992;14:617-618.
  • Cohen SE,Woods WA, Wyner j, Antiemetic efficacy of droperidol and metoclopramide. Anaesthesiology 1984;60:6-69.
  • Jimenez-Jimenez FJ, Molina JA. Drug- induced movement disor- ders. Drug Safety 1997;16:180-204.
  • Hughes RAC, Rees JH. Clinical and epidemiological features of Guillain-Barré syndrome. J Infect Dis 1997;176:S92-S98.
  • Valenzuela JE, Dooley CP. Dopamine antagonists in the upper gas- trointestinal tract. Scand J Gastroenterol Suppl 1984;96:127-36.
  • Massara F, Tangolo D, Godano A, Goffi S, Bertagna A, Molinatti GM. Effect of metoclopramide, domperidone, and apomorphine on GH secretion in children and adolescents. Acta Endocrinol 1985;108:451-5.
  • Jolliet P, Nion S, Allain-Veyrac G, Tilloy-Fenart L, Vanuxeem D, Cecchelli R. Evidence of lowest brain penetration of an antiemetic drug, metopimazine, compared to domperidone, metoclopramide and chlorpromazine, using an in vitro model of the blood–brain barrier. Pharmacol Res 2007;56:11-17.
  • Parlak I, Erdur B, Parlak M, Ergin A, Turkcuer I, Tomruk O, et al. Intravenous administration of metoclopramide by 2 min bolus vs 15 min infusion: does it affect the improvement of headache while reducing the side effects? Postgrad Med J 2007;83:664-668.
  • tone AG, Howell PR. An unusual complication of metoclopramide injection. Anaesthesia. 2003;58:817-8.
  • Dingli K, Morgan R, Leen C.Acute dystonic reaction caused by metoclopramide, versus tetanus. BMJ. 2007;334:899-900.
  • Moos DD, Hansen DJ. J Perianesth Nurs. Metoclopramide and ex- trapyramidal symptoms: a case report. 2008;23:292-9.

Is ‘Paraparesis’, A Rare Symptom Of Metoclopramide?: A Case Report

Yıl 2011, Cilt: 2 Sayı: 2, 41 - 43, 01.04.2011

Sadiye Yolcu Uysal Nesrin Gökben Çetin Önder Tomruk

Öz

Metoclopramide is a procinetic and atiemetic agent, used to increase gastrintestinal system motility. In case, acute muscle weakness is one of the most neuromuscular emergencies seen in the emergency service and have several ethiological causes. In our study we aimed to introduce a case who was treated with metoclopramide in therapeutic dose and sustained muscle weakness in 12-24 hours and to overview the potential side effects of this drug

Anahtar Kelimeler

Metoclopramide Procinetic Agent Neuromuscular Emergencies

Kaynakça

  • Batts KF, Munter DW. Metoclopramid toxicity in an infant. Pedi- atr Emerg Care 1998;14: 39-41.
  • Bateman DN, Rawlins MD, Simpson JM. Extrapiramidal reac- tions with metoclopramide. BMJ 1985;291:930-932.
  • Guala A, Mittino D, Ghini T, Quazza G. Are metoclopramide dys- tonias familial? Pediatr Med Chir 1992;14:617-618.
  • Cohen SE,Woods WA, Wyner j, Antiemetic efficacy of droperidol and metoclopramide. Anaesthesiology 1984;60:6-69.
  • Jimenez-Jimenez FJ, Molina JA. Drug- induced movement disor- ders. Drug Safety 1997;16:180-204.
  • Hughes RAC, Rees JH. Clinical and epidemiological features of Guillain-Barré syndrome. J Infect Dis 1997;176:S92-S98.
  • Valenzuela JE, Dooley CP. Dopamine antagonists in the upper gas- trointestinal tract. Scand J Gastroenterol Suppl 1984;96:127-36.
  • Massara F, Tangolo D, Godano A, Goffi S, Bertagna A, Molinatti GM. Effect of metoclopramide, domperidone, and apomorphine on GH secretion in children and adolescents. Acta Endocrinol 1985;108:451-5.
  • Jolliet P, Nion S, Allain-Veyrac G, Tilloy-Fenart L, Vanuxeem D, Cecchelli R. Evidence of lowest brain penetration of an antiemetic drug, metopimazine, compared to domperidone, metoclopramide and chlorpromazine, using an in vitro model of the blood–brain barrier. Pharmacol Res 2007;56:11-17.
  • Parlak I, Erdur B, Parlak M, Ergin A, Turkcuer I, Tomruk O, et al. Intravenous administration of metoclopramide by 2 min bolus vs 15 min infusion: does it affect the improvement of headache while reducing the side effects? Postgrad Med J 2007;83:664-668.
  • tone AG, Howell PR. An unusual complication of metoclopramide injection. Anaesthesia. 2003;58:817-8.
  • Dingli K, Morgan R, Leen C.Acute dystonic reaction caused by metoclopramide, versus tetanus. BMJ. 2007;334:899-900.
  • Moos DD, Hansen DJ. J Perianesth Nurs. Metoclopramide and ex- trapyramidal symptoms: a case report. 2008;23:292-9.
Toplam 13 adet kaynakça vardır.

Ayrıntılar

Diğer ID JA55TN37RN
Bölüm Araştırma Makalesi
Yazarlar

Sadiye Yolcu Uysal Bu kişi benim

Nesrin Gökben Çetin Bu kişi benim

Önder Tomruk Bu kişi benim

Yayımlanma Tarihi 1 Nisan 2011
Gönderilme Tarihi 1 Nisan 2011
Yayımlandığı Sayı Yıl 2011 Cilt: 2 Sayı: 2

Kaynak Göster

APA Uysal, S. Y., Çetin, N. G., & Tomruk, Ö. (2011). Is ‘Paraparesis’, A Rare Symptom Of Metoclopramide?: A Case Report. Journal of Emergency Medicine Case Reports, 2(2), 41-43.
AMA Uysal SY, Çetin NG, Tomruk Ö. Is ‘Paraparesis’, A Rare Symptom Of Metoclopramide?: A Case Report. Journal of Emergency Medicine Case Reports. Nisan 2011;2(2):41-43.
Chicago Uysal, Sadiye Yolcu, Nesrin Gökben Çetin, ve Önder Tomruk. “Is ‘Paraparesis’, A Rare Symptom Of Metoclopramide?: A Case Report”. Journal of Emergency Medicine Case Reports 2, sy. 2 (Nisan 2011): 41-43.
EndNote Uysal SY, Çetin NG, Tomruk Ö (01 Nisan 2011) Is ‘Paraparesis’, A Rare Symptom Of Metoclopramide?: A Case Report. Journal of Emergency Medicine Case Reports 2 2 41–43.
IEEE S. Y. Uysal, N. G. Çetin, ve Ö. Tomruk, “Is ‘Paraparesis’, A Rare Symptom Of Metoclopramide?: A Case Report”, Journal of Emergency Medicine Case Reports, c. 2, sy. 2, ss. 41–43, 2011.
ISNAD Uysal, Sadiye Yolcu vd. “Is ‘Paraparesis’, A Rare Symptom Of Metoclopramide?: A Case Report”. Journal of Emergency Medicine Case Reports 2/2 (Nisan 2011), 41-43.
JAMA Uysal SY, Çetin NG, Tomruk Ö. Is ‘Paraparesis’, A Rare Symptom Of Metoclopramide?: A Case Report. Journal of Emergency Medicine Case Reports. 2011;2:41–43.
MLA Uysal, Sadiye Yolcu vd. “Is ‘Paraparesis’, A Rare Symptom Of Metoclopramide?: A Case Report”. Journal of Emergency Medicine Case Reports, c. 2, sy. 2, 2011, ss. 41-43.
Vancouver Uysal SY, Çetin NG, Tomruk Ö. Is ‘Paraparesis’, A Rare Symptom Of Metoclopramide?: A Case Report. Journal of Emergency Medicine Case Reports. 2011;2(2):41-3.